Liquid Biopsy’s Saga Continues with New Financing
Liquid Biopsy Tests Are Becoming More Mainstream
Meet Thrive: The New Kid on the Liquid Biopsy Block
Could Myriad’s New Study Results Be Game Changers For Cancer Patients?
Quest Diagnostics Data Breach Could Impact Nearly 12M Customers
Grail Presents Early Favorable CCGA Data at ASCO
Resolution Bioscience Granted Breakthrough Device Designation from FDA
That's a First: FDA Tackles STDs, Zika, and Prosthetic Joint Infection
The Best Colon Cancer Screening Test Is the One That Gets Done
Grail Sets Fast Pace in Liquid Biopsy with New Milestones